ARCHIVES

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

This article is from The Cancer Letter archive.

Vol. 38 No. 07 | February 17, 2012

Download PDF Visit The Full Archive

Related Articles

DCE Board Demands Other Agencies Pay For NCI AIDS Support Contract, Okays Two RFA Concepts, One Program Announcement, Contract Recompetitions

May 24, 1985

Upton Still Mum On Leaving; DeVita Ever More Likely as Replacement

November 30, 1979

NCI, Six Centers Begin Feasibility Study Of Spiral CT For Lung Cancer Screening.

September 8, 2000

CDC To Award $23 Mil. To States for Screening

April 26, 1991

FASEB urges 10 percent increase for NIH in FY 2005.

January 23, 2004

Murray Copeland Display Dedicated

March 18, 1983